Calkins H, Seifert M, Morady F
Department of Internal Medicine, University of Michigan, Ann Arbor, USA.
Am Heart J. 1995 Jun;129(6):1159-64. doi: 10.1016/0002-8703(95)90398-4.
The purpose of this study is to report on a series of patients who were referred for evaluation of syncope that occurred during or immediately after exercise and in whom a diagnosis of vasodepressor syncope was established (9 women and 8 men; mean age of 28 +/- 17 years). The approach to management was individualized in each patient. All patients were monitored to determine the frequency and type of recurrent symptoms. The mean age at onset of symptoms was 23 +/- 16 years. In 10 patients syncope occurred only in association with exercise. Pharmacologic therapy was successful in normalizing the patients' response to upright tilt in each of the 10 patients in whom it was attempted. During a mean follow-up period of 35 +/- 9 months, none of the patients placed on pharmacologic therapy has had recurrent syncope. Seventeen (88%) of 19 patients have resumed participation in athletics. The results of this study demonstrate that vasodepressor syncope is a cause of syncope in athletes and that patients with exercise-related vasodepressor syncope can safely continue to participate in athletics.
本研究的目的是报告一系列因运动期间或运动后立即发生晕厥而前来评估的患者，这些患者被诊断为血管减压性晕厥（9名女性和8名男性；平均年龄28±17岁）。对每位患者的管理方法都是个体化的。所有患者均接受监测以确定复发症状的频率和类型。症状开始出现时的平均年龄为23±16岁。10名患者的晕厥仅与运动有关。在尝试进行药物治疗的10名患者中，药物治疗成功使患者对直立倾斜试验的反应恢复正常。在平均35±9个月的随访期内，接受药物治疗的患者均未出现复发性晕厥。19名患者中有17名（88%）已恢复参加体育活动。本研究结果表明，血管减压性晕厥是运动员晕厥的一个原因，且与运动相关的血管减压性晕厥患者可以安全地继续参加体育活动。
